Table 3.
TTC (%) n = 95 (SD) |
Anterior STEMI (%) n = 101 (SD) |
p | |
---|---|---|---|
GP IIb/IIIa inhibitors | – | 31,7 | – |
– Abciximab | – | 12.9 | – |
– Eptifibatide | – | 18.8 | – |
Heparin | 91.6 | 98.0 | 0.0419 |
– Unfractionated heparin | 36.8 | 57.4 | 0.0038 |
– Enoxaparin | 52.6 | 40.6 | 0.092 |
– Fondaparinux | 2.1 | 0.0 | 0.146 |
Nitroglycerin | 14.7 | 31.7 | 0.0051 |
Clopidogrel | 82.1 | 99 | <0.0001 |
Aspirin | 97.9 | 98.0 | 0.951 |
Statins | 89.5 | 86.1 | 0.477 |
Beta blockers | 87.4 | 89.1 | 0.705 |
ACEI/ARB | 89.5 | 82.2 | 0.144 |
ACEI | 82.1 | 79.2 | 0.608 |
ARB | 7.4 | 3.0 | 0.163 |
Calcium blockers | 8.4 | 5.9 | 0.501 |
Diuretics | 49.5 | 70.3 | 0.0029 |
Proton pump inhibitors | 74.7 | 90.1 | 0.0045 |
Pressor amines | 13.7 | 22.0 | 0.130 |
Intra-aortic balloon pump | 2.11 | 7.14 | 0.097 |
ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, IABP intra-aortic balloon pump